$63,239,785

Department of Health and Human Services·Office of Assistant Secretary for Preparedness and Response

to ARCTURUS THERAPEUTICS, INC.

healthexpiring · 51d· period of performance ends in 51 daysONGOING · MOD OF 2022 CONTRACT

WORK BEGAN2022-09-01·LATEST ACTION2026-03-20·SOURCEUSASPENDING·SOURCE IDCONT_AWD_75A50122C00007_7505_-NONE-_-NONE-

Award description

PROCURE A PANDEMIC INFLUENZA VACCINE (PANDFLU) AND A QUADRIVALENT SEASONAL INFLUENZA VACCINE (QSFLU)

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

Latest obligation on a 2022 pandemic influenza and seasonal flu vaccine procurement contract with Arcturus Therapeutics.

Sub-sectors

vaccine-procurementpandemic-preparednessinfluenza

Why this matters

Ensures domestic vaccine supply chain resilience for pandemic and seasonal influenza protection as part of HHS preparedness strategy.

Supply-chain signal

Signals continued reliance on Arcturus for mRNA/viral vector vaccine manufacturing capacity; supports domestic production capability for rapid pandemic response.

U.S.–China competition angle

Reduces dependence on foreign vaccine suppliers; strengthens U.S. biotech manufacturing autonomy in pandemic countermeasures.

Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-06-05. Cost: $0.002908.

Period of performance

Start

2022-09-01

End

2026-08-20

Status

expiring · 51din 51 days

Recipient

ARCTURUS THERAPEUTICS, INC.

UEI E3MFDBN4L3J9

View full profile →

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier CONT_AWD_75A50122C00007_7505_-NONE-_-NONE-.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.